revakinagene taroretcel-lwey

FDA Drug Profile — ENCELTO

Drug Details

Generic Name
revakinagene taroretcel-lwey
Brand Names
ENCELTO
Application Number
BLA125798
Sponsor
Neurotech Pharmaceuticals, Inc.
NDC Codes
1
Dosage Forms
IMPLANT
Routes
INTRAVITREAL
Active Ingredients
REVAKINAGENE TARORETCEL

Indications and Usage

1 INDICATIONS AND USAGE ENCELTO is indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel). ENCELTO is an allogeneic encapsulated cell-based gene therapy indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel).